02 May 2003
Inhibitors of poly(ADP-ribose) polymerase activity as interventions against renal ischemia/reperfusion injury and acute renal failureP. Chatterjee, M. McDonald, M. Threadgill, C. Thiemermann
Med Sci Monit 2003; 9(1): 10-0 :: ID: 15056
Excessive activation of PARP contributes to the renal dysfunction and injury caused by reactive oxygen species (ROS), nitric oxide and peroxynitrite . However, most inhibitors of PARP activity are either weak inhibitors (e.g. 3-aminobenzamide) or are soluble in dimethyl sulphoxide (e.g. 5-dihydroxyisoquinoline). We therefore investigated the effects of the water-soluble PARP inhibitor, 5-aminoisoquinolinone (5-AIQ), on the (i) renal dysfunction caused by 45 min ischaemia followed by 6 h reperfusion (I/R) in vivo and (ii) cytotoxicity caused by exposure of rat proximal tubular (PT) cells to oxidative stress (1 mM H2O2 for 4 h) in vitro.Renal I/R produced a significant increase in serum creatinine levels (indicating renal dysfunction) which was reduced significantly by 5-AIQ (Table 1). Incubation of rat PT cells with H2O2 increased LDH significantly (indicating renal cytotoxicity) (Table 2), however, incubation with H2O2 and 5-AIQ produced a significant reduction in LDH release (Table 2).Thus we propose that PARP inhibitors may be useful in conditions which involve renal ischaemia and reperfusion (e.g. renal transplantation).References: 1.Chatterjee PK, Thiemermann C: Poly(ADP-ribose) polymerase inhibitors and acute renal failure. In: Zhang J (ed.): Therapeutic Utilities of PARP Inhibitors. CRC Press; Boca Raton, 2002, pp. 149-168
Keywords: renal, Kidney, proximal tubular cells, poly(ADP-ribose) polymerase, poly(ADP-ribose) polymerase inhibitor, 5-aminoisoquinolinone, 5-dihydroxyisoquinolinoline
01 June 2023 : EditorialEditorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness
Med Sci Monit 2023; 29:e941209
08 Jun 2023 : Clinical ResearchRisk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...
Med Sci Monit In Press; DOI: 10.12659/MSM.940134
08 Jun 2023 : Clinical ResearchA Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...
Med Sci Monit In Press; DOI: 10.12659/MSM.940124
08 Jun 2023 : Clinical ResearchBurden of COVID-19 on Mental Health of Resident Doctors in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940208
08 Jun 2023 : Clinical ResearchRisk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...
Med Sci Monit In Press; DOI: 10.12659/MSM.940251
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952